Four or More CT Scans in Childhood Linked to Increased Risk of Cancer
Exposure to 4 or more CT scans before the age of 18 is associated with an increased risk of intracranial tumors, leukemia, and lymphoma, a study suggests.
Diagnosis & Disease Information
Polivy Combination Therapy Approved for Previously Untreated DLBCL
Polivy plus R-CHP is approved for the first-line treatment of patients with DLBCL NOS or HGBL who have an IPI score of 2 or greater.
Bispecific CAR T-Cell Therapy Has “Robust” Activity in Non-Hodgkin Lymphoma
A bispecific CAR T-cell therapy produced responses in 91% of patients with relapsed/refractory non-Hodgkin lymphoma in a phase 1 trial.
AFM13 Proves Active in Relapsed/Refractory PTCL, Especially AITL
The bispecific antibody AFM13 elicits responses in patients with relapsed/refractory peripheral T-cell lymphoma, a phase 2 study suggests.
Pediatric Cancer Survivors Have 4-Fold Higher Risk of Death 40 Years After Diagnosis
From 15 to 40 years after diagnosis, pediatric cancer survivors have a roughly 4-fold higher risk of death than the general population, a study suggests.
EPA Aims to Reduce Exposure to Ethylene Oxide Due to Cancer Risk
The EPA aims to slash emissions of ethylene oxide because long-term exposure to the gas raises the risk of certain cancers.
Imbruvica No Longer Approved to Treat MCL, MZL in the US
AbbVie and Janssen are withdrawing the accelerated approvals of Imbruvica for mantle cell lymphoma and marginal zone lymphoma.
Many Childhood Cancer Survivors Report Late Effects More Than 15 Years After Diagnosis
Survivors of childhood cancer may experience a range of late effects more than 15 years after diagnosis, a new study suggests.
Pembrolizumab Plus ICE Deemed Effective in Relapsed/Refractory Hodgkin Lymphoma
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.
- Loading...
Loading...
Next post in Pediatric Cancer
Loading... 
Loading...